Watching Pfizer; Live On CNBC, Josh Brown Says "Pfizer YTD Truly Stunning", Naming It His Chart Of The Year; Shares Move Higher On Volume
Portfolio Pulse from Benzinga Newsdesk
Josh Brown highlighted Pfizer's year-to-date performance as 'truly stunning' on CNBC, calling it his 'Chart of the Year.' Following his comments, Pfizer shares saw an increase in volume and moved higher.
December 19, 2023 | 5:39 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Pfizer's stock experienced higher volume and an increase in share price following Josh Brown's positive comments on CNBC.
Josh Brown's comments on a major financial news network like CNBC can influence investor sentiment and lead to increased trading activity. His positive remarks about Pfizer's performance are likely to boost investor confidence in the short term, leading to a temporary rise in stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100